VIP1–12 Is a Ligand for the CD4/Human Immunodeficiency Virus Receptor
- 1 June 1988
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 527 (1) , 574-578
- https://doi.org/10.1111/j.1749-6632.1988.tb27010.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Cholecystokinin and the immune system: Receptor-mediated chemotaxis of human and rat monocytesPeptides, 1988
- HTLV-III large envelope protein (gp120) suppresses PHA-induced lymphocyte blastogenesis.The Journal of Immunology, 1987
- CD4 receptor binding peptides that block HIV infectivity cause human monocyte chemotaxisFEBS Letters, 1987
- Octapeptides deduced from the neuropeptide receptor-like pattern of antigen T4 in brain potently inhibit human immunodeficiency virus receptor binding and T-cell infectivity.Proceedings of the National Academy of Sciences, 1986
- VASO‐ACTIVE INTESTINAL PEPTIDE: A NEUROTRANSMITTER WHICH REDUCES HUMAN NK CELL ACTIVITY AND INCREASES Ig SYNTHESISImmunology & Cell Biology, 1985
- Immunologic Abnormalities in the Acquired Immunodeficiency SyndromeAnnual Review of Immunology, 1985
- T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAVNature, 1984
- The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirusNature, 1984
- Interaction of vasoactive intestinal peptide with mouse lymphocytes: specific binding and the modulation of mitogen responses.The Journal of Immunology, 1984
- Is the vasoactive intestinal peptide (VIP) a prohormone?Bioorganic Chemistry, 1979